Loading...
XNSE
ZOTA
Market cap487mUSD
Nov 12, Last price  
1,532.50INR
Name

Zota Health Care Ltd

Chart & Performance

D1W1MN
XNSE:ZOTA chart
P/E
P/S
8.63
EPS
Div Yield, %
0.07%
Shrs. gr., 5y
6.03%
Rev. gr., 5y
38.22%
Revenues
5.39b
+83.86%
381,430,000376,639,000439,081,000501,116,000564,634,000647,333,000715,799,819778,515,315852,332,828951,127,0001,067,892,0001,311,931,0001,399,569,0001,804,885,0002,929,748,0005,386,575,000
Net income
-739m
L+31.10%
19,834,00019,834,00025,545,00031,298,00042,603,00051,092,90155,410,98672,676,69355,483,00027,415,000-2,089,00089,076,000-57,728,000-143,479,000-563,984,000-739,361,000
CFO
-790m
L+61.42%
49,259,00025,349,00027,629,00029,984,00042,823,00045,585,47033,530,339-44,291,673-32,471,00055,572,000-8,896,000133,320,000-20,061,000-59,842,000-489,472,000-790,122,000
Dividend
Sep 22, 20251 INR/sh
Earnings
Nov 10, 2026

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.
IPO date
May 10, 2017
Employees
Domiciled in
IN
Incorporated in
IN

Valuation

Title
INR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT